STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
62 hedge funds and large institutions have $96.3M invested in Stemline Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $416K
Holders
62
Holding in Top 10
–
Calls
–
Puts
$416K
Top Buyers
| 1 | +$418K | |
| 2 | +$380K | |
| 3 | +$336K | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$272K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$201K |
Top Sellers
| 1 | -$1.41M | |
| 2 | -$818K | |
| 3 | -$334K | |
| 4 |
Canada Life
Winnipeg,
Manitoba, Canada
|
-$297K |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$255K |